The nation of Zimbabwe has rejected a significant US healthcare agreement valued at $367m (£272m) over five years due to Washington's demand for confidential data.
This move became public following a internal memorandum from December was disclosed, indicating that Head of State Emmerson Mnangagwa felt the deal was "lopsided".
A government spokesperson has since stated that the US was requesting health data for research and commercial gain while refused to guarantee the resulting advantages from future medical innovations.
"We are forced to start the challenging and unfortunate process of scaling back our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had provided over $1.9bn in health funding to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has urged further dialogue to find a agreement acceptable to all parties so the country's critical HIV programme can proceed.
Wider Context
Zimbabwe's decision follows a similar situation in Kenya, where a court suspended a similar deal with the US after concerns were raised about the security of citizens' medical information.
After resuming office last year, US President Donald Trump has reduced foreign aid and closed the key foreign aid agency.
USAID had managed aid for the US government, but Trump claimed its expenditure was "inefficient" and his government was seeking government-to-government deals to boost openness and responsibility.
As per reports, 16 nations in Africa have so far signed these new health pacts, representing over $18.3bn in new funding.
Specifics of the Declined Deal
This assistance for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this cooperation would have delivered significant advantages for the people of Zimbabwe, especially the 1.2 million men, women and children presently on HIV treatment through US-supported programmes," the Ambassador commented.
However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".
"The proposal required Zimbabwe to share its biological resources and data for a long time, with no corresponding promise of benefiting from any scientific breakthroughs – such as new medicines or tests – that might result from that shared data," his statement read.
"In essence, our nation would provide the raw materials for medical research with no certainty that the final treatments would be available to our citizens should a future disease outbreak emerge."
Sovereignty and International Frameworks
Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were disrupting structures previously established via the international organization.
Mangwana cited its Pandemic Benefit-Sharing framework created to deal with future global health emergencies.
"This system is intended to guarantee that when a country provides its samples, the resulting advantages – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the capability to create them."
The government's concerns regarding the US deal "must not be interpreted as anti-American sentiment," he added.
"We are open to continued dialogue with our American counterparts on how subsequent collaboration might be arranged in a way that honours the independence and interests of each country."
Health Experts Response
Medical experts expressed it acknowledged the government's concerns, but suggested that talks must proceed considering much of the nation's HIV programmes depended on foreign aid.
"If specific concerns exist, including those involving data governance or agreement terms, these can often be resolved through detailed discussion and mutually agreed protections," it said.
This impasse underscores the continuing tensions between receiving crucial foreign assistance and protecting a country's data in an increasingly data-driven world.